SCHEMBL6660100

SCHEMBL6660100

O=c1occc(O)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12501831 0.97 KDM4E (0.58)
SCHEMBL27718563 0.75
SCHEMBL23941080 0.75
SCHEMBL580718 0.75
SCHEMBL7965306 0.75
SCHEMBL10338153 0.72 KDM4E (0.52)
SCHEMBL28594543 0.72 GABRA1 (0.48)
SCHEMBL27920891 0.70 KDM4E (0.50)
SCHEMBL24376271 0.70 KDM4E (0.55)
SCHEMBL23925707 0.69 HDAC4 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279621-A1 NOVEL LUCIFERASES AND METHODS FOR USING SAME LIGHT BIO INC (US) 2024-08-22 US claimed
EP-2668175-B2 PROCESS FOR PREPARING AN IRON HYDROXYPYRONE SHIELD TX UK LTD (GB) 2021-01-06 EP claimed
EP-2668175-B1 PROCESS FOR PREPARING AN IRON HYDROXYPYRONE SHIELD TX (UK) LTD (GB) 2017-03-08 EP claimed
EP-0892774-A4 PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO ANADYS PHARMACEUTICALS INC (US) 2001-10-04 EP claimed
US-6127551-A 4-HYDROXY-6-ETHYOXYCARBONYLALKENYL-2H-PYRAN-2-ONE IS ACYLATED WITH PROPIONYL CHLORIDE TO FORM A KETONE ADDUCT, FOLLOWED BY BASE-CATALYZED ALDOL TO FROM A PYRONE ALDOL; MESYLATION, FORM A PYRONE KETONE; AND CURTIUS SEQUENCE TO FORM MYXOPYRONIN SCRIPTGEN PHARMACEUTICALS, INC. (US) 2000-10-03 US claimed
EP-0892774-A2 PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO SCRIPTGEN PHARMACEUTICALS, INC. (US) 1999-01-27 EP claimed
WO-1997034569-A2 PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES SCRIPTGEN PHARMACEUTICALS, INC. (US) 1997-09-25 WO claimed
JP-54081273-A None JP disclosed
US-20260043011-A1 Luminescent Protein OSAKA UNIVERSITY (JP) 2026-02-12 US disclosed
EP-4213833-B1 KOJIC ACID DERIVATIVE AS SELECTIVE INHIBITOR OF MITOSIS IN COLORECTAL AND GLIOBLASTOMA CANCER CELLS UNIV DEGLI STUDI CAGLIARI (IT) 2024-09-18 EP disclosed
CN-110234758-B Novel luciferases and methods of use thereof 普兰塔有限公司 2024-08-27 CN disclosed
US-20240279621-A1 NOVEL LUCIFERASES AND METHODS FOR USING SAME LIGHT BIO INC (US) 2024-08-22 US disclosed
US-20240117385-A1 ENZYMES OF LUCIFERIN BIOSYNTHESIS AND USE THEREOF LIGHT BIO INC (US) 2024-04-11 US disclosed
WO-1999034793-A1 PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO SCRIPTGEN PHARMACEUTICALS, INC. (US) 1999-07-15 WO disclosed
EP-0892774-A2 PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO SCRIPTGEN PHARMACEUTICALS, INC. (US) 1999-01-27 EP disclosed
EP-0877287-A1 Developer for silver halide light sensitive photographic material and processing method by use thereof KONICA CORPORATION (JP) 1998-11-11 EP disclosed
EP-0833627-A2 IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF Vitra Pharmaceuticals Ltd. (GB) 1998-04-08 EP disclosed
WO-1997034569-A2 PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES SCRIPTGEN PHARMACEUTICALS, INC. (US) 1997-09-25 WO disclosed
WO-1996041627-A2 IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF VITRA PHARMACEUTICALS LTD (GB) 1996-12-27 WO disclosed
JP-S5481273-A PREPARATION OF PYRANONE HALIDE SHIN ETSU CHEM CO LTD 1979-06-28 JP disclosed